[The YY3-36 peptide, a new therapeutic weapon against obesity?].
Jégou
Sylvie
S
Mounien
Lourdes
L
Boutelet
Isabelle
I
Vaudry
Hubert
H
D000328:Adult; D054369:Agouti-Related Protein; D000818:Animals; D001067:Appetite Depressants / Q000627:therapeutic use*; D002766:Cholecystokinin / Q000502:physiology; D003106:Colon / Q000378:metabolism; D018849:Controlled Clinical Trials as Topic; D054439:Ghrelin; D006706:Homeostasis; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D036341:Intercellular Signaling Peptides and Proteins; D007421:Intestine, Small / Q000378:metabolism; D020738:Leptin / Q000502:physiology; D008954:Models, Biological; D009478:Neuropeptide Y / Q000502:physiology; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D010446:Peptide Fragments; D036361:Peptide Hormones / Q000502:physiology; D019894:Peptide YY / Q000378:metabolism / Q000627:therapeutic use*; D011333:Pro-Opiomelanocortin / Q000502:physiology; D011506:Proteins / Q000502:physiology; D051381:Rats; D012528:Satiety Response / Q000502:physiology*; D000521:alpha-MSH / Q000502:physiology
D054369:Agouti-Related Protein; D001067:Appetite Depressants; D054439:Ghrelin; D036341:Intercellular Signaling Peptides and Proteins; D020738:Leptin; D009478:Neuropeptide Y; D010446:Peptide Fragments; D036361:Peptide Hormones; D011506:Proteins; D019894:Peptide YY; C061785:peptide YY (3-36); D000521:alpha-MSH; D011333:Pro-Opiomelanocortin; D002766:Cholecystokinin